USPTO issues Patent for ground breaking polysaccharide technology platform to Endomedix.
Posted: January 9, 2020Montclair, NJ, January 8, 2020 – Endomedix announced today that it received a patent of 30 issued claims for its PLEXimine™ Polysaccharide Technology platform for a new class of biomaterials. The patent, “Methods and Compositions for Achieving Hemostasis and Stable Clot Formation”, also covers design features and mechanisms of action for its first product based […]
Read More ›Endomedix’s PLEXimine technology featured on the cover of Journal of Applied Polymer Science
Posted: December 13, 2019Endomedix Joins US Army Medical Research Groups in CRADA for Ocular Projectile Battlefield Trauma Project
Posted: October 11, 2019Montclair, NJ, October 11, 2019 – Endomedix, Inc. announced today that it has entered into a Cooperative Research and Development Agreement or CRADA with the US. Army Institute of Surgical Research (USAISR) and the U.S. Army Medical Materiel Development Activity (USAMMDA). The CRADA will address a specific topic, “Ocular Projectile Battlefield Trauma Project”, an unsolved […]
Read More ›Endomedix publishes ground breaking research and method development for the use of biologically derived polysaccharides in implantable medical devices in peer reviewed journal
Posted: September 10, 2019Montclair, NJ, September 10th 2019 – Endomedix, Inc. announced today the first of a series of publications of its research and patented technology for a new family of biomaterials based on natural polysaccharides. Appearing in the Journal of Applied Polymer Science, the article, “Reproducible, biocompatible medical materials from biologically derived polysaccharides: Processing and Characterization”, addresses […]
Read More ›Poster at Military Health System Research Symposium (MHSRS) 2019
Posted: August 6, 2019Endomedix, Inc. to present its innovative technology addressing the needs of Warfighters at the upcoming Military Health System and Research Symposium 2019 annual meeting
Posted: August 6, 2019Montclair, NJ, August 6th 2019 – Endomedix, Inc., today announced that it will present its patented revolutionary technology to control bleeding in battlefield injuries at the upcoming Military Health System and Research Symposium (MHSRS) annual meeting. Loss of blood still remains the most common cause of potentially preventable deaths in battlefield casualties, two-thirds of such […]
Read More ›Poster at Society For Biomaterials Annual Meeting 2019
Posted: March 26, 2019Endomedix, Inc. to Present at Upcoming Society For Biomaterials 2019 Annual Meeting
Posted: February 26, 2019Presentation of “New Technology to Reduce Complications and Procedure Time in Cranial and Spinal Surgery” to be the first of several upcoming presentations and publications MONTCLAIR, NJ, February 26, 2019 – Endomedix, Inc., a developer of unique biosurgical products based on natural biopolymer systems, today announced it will provide the first public presentation of […]
Read More ›Endomedix, Inc. Announces Submission of Patent Application for Advanced Hemostat Technology
Posted: December 12, 2018First Biosurgery Product Targets Brain and Spinal Surgery Indications MONTCLAIR, NJ, December 12, 2018 – Endomedix, Inc., a developer of unique biosurgical products based on its natural biopolymer systems, today announced that it has submitted a comprehensive patent application to protect both its latest chemistry technology and also the design and function of the spray-on […]
Read More ›